Dr Reddy’s, R-Pharm of Russia enter into agreement

The agreement, in the areas of high-technology and knowledge sharing, will entail licensing of manufacturing know-how of products by Dr Reddy’s, local manufacturing of products in Russia, co-development of high technology products and knowledge sharing between both parties at regular intervals.

Dr Reddy’s MD and COO Satish Reddy said the agreement allows them to bring innovative medicines to the Russian people with active collaboration of a local pharmaceutical company- R-Pharm.

"It will also allow Dr Reddy’s to import and market R-Pharm products in India according to agreed terms. The collaboration demonstrates our commitment to play a leading role in supporting the Russian Government’s policy of Pharma 2020," Reddy said.

R-Pharm chairman Alexey Repik said this agreement helps address unmet medical needs in important therapeutic areas and make medicines more affordable to patients in Russia.

"It also pioneers a new way of collaboration between an Indian and a Russian pharmaceutical company. It is a change of approach from just imports of finished products to deep integration in technology, manufacturing, marketing and knowledge sharing," Repik said.

R-Pharm is involved in R&D, manufacturing, promotion and distribution of pharmaceuticals used in hospital and specialty care.

Key areas of competence of R-Pharm include: manufacturing of finished drugs and APIs, research and development of innovative pharmaceutical products and technologies, distribution, training and education for industry and health care specialists.